Rapid Micro Biosystems, Inc.
RPIDNASDAQHealthcare● Active
$1.98
$-0.01(-0.50%)
Market Cap$89738114
P/E Ratio—
52W High$4.94
52W Low$1.86
Rapid Micro Biosystems, Inc. (RPID) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RPID · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.31
Est. -$0.25 · -24.0%
Revenue
$0.01B
Est. $0.01B · +5.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
RPID reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.26 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.25 | -$0.31 | -24.0% | $0.01B | $0.01B | +5.3% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -$0.23 | -$0.28 | -21.7% | $0.01B | $0.01B | -0.6% |
| — Q4 FY2025 | Nov 7, 2025 | -$0.26 | -$0.26 | +0.0% | $0.01B | $0.01B | -28.3% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.26 | -$0.27 | -3.9% | $0.01B | $0.01B | -12.9% |
| ▲ Q2 FY2025 | May 9, 2025 | -$0.27 | -$0.26 | +3.7% | $0.01B | $0.01B | +4.9% |
| — Q1 FY2025 | Feb 28, 2025 | -$0.22 | -$0.22 | +0.0% | $0.01B | $0.01B | +0.2% |
| — Q4 FY2024 | Nov 1, 2024 | -$0.26 | -$0.26 | +0.0% | $0.01B | $0.01B | +0.1% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.26
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.31
EPS Est.
-$0.25
EPS Surpr.
-24.0%
Revenue
$0.01B
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
-$0.28
EPS Est.
-$0.23
EPS Surpr.
-21.7%
Revenue
$0.01B
Q4 FY2025
Nov 7, 2025
EPS Actual
-$0.26
EPS Est.
-$0.26
EPS Surpr.
+0.0%
Revenue
$0.01B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.26
EPS Surpr.
-3.9%
Revenue
$0.01B
Q2 FY2025
May 9, 2025Beat
EPS Actual
-$0.26
EPS Est.
-$0.27
EPS Surpr.
+3.7%
Revenue
$0.01B
Q1 FY2025
Feb 28, 2025
EPS Actual
-$0.22
EPS Est.
-$0.22
EPS Surpr.
+0.0%
Revenue
$0.01B
Q4 FY2024
Nov 1, 2024
EPS Actual
-$0.26
EPS Est.
-$0.26
EPS Surpr.
+0.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.18 | $-0.18 | $-0.17 | 1 |
| Q3 FY2026 | $-0.21 | $-0.20 | $-0.19 | 2 |
| Q2 FY2026 | $-0.25 | $-0.24 | $-0.24 | 2 |
| Q1 FY2026 | $-0.25 | $-0.25 | $-0.24 | 2 |
| Q4 FY2025 | $-0.22 | $-0.22 | $-0.22 | 2 |
| Q3 FY2025 | $-0.25 | $-0.24 | $-0.23 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -24.0% | $2.58 | $2.48 | -3.88% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -21.7% | $4.38 | $3.43 | -21.69% |
| ▲ Q4 FY2025 | Nov 7, 2025 | +0.0% | $2.75 | $3.10 | +12.73% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -3.9% | $3.26 | $2.68 | -17.79% |
| ▲ Q2 FY2025 | May 9, 2025 | +3.7% | $2.45 | $3.08 | +25.71% |
| ▲ Q1 FY2025 | Feb 28, 2025 | +0.0% | $3.31 | $3.05 | -7.85% |
| ▲ Q4 FY2024 | Nov 1, 2024 | +0.0% | $1.08 | $1.10 | +1.85% |
| ▼ Q3 FY2024 | Aug 2, 2024 | -3.6% | $0.68 | $0.80 | +17.26% |
Q2 FY2026-3.88%
Report Date
May 13, 2026
EPS Beat/Miss
-24.0%
Price Before
$2.58
Price After
$2.48
Q1 FY2026-21.69%
Report Date
Mar 12, 2026
EPS Beat/Miss
-21.7%
Price Before
$4.38
Price After
$3.43
Q4 FY2025+12.73%
Report Date
Nov 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.75
Price After
$3.10
Q3 FY2025-17.79%
Report Date
Aug 12, 2025
EPS Beat/Miss
-3.9%
Price Before
$3.26
Price After
$2.68
Q2 FY2025+25.71%
Report Date
May 9, 2025
EPS Beat/Miss
+3.7%
Price Before
$2.45
Price After
$3.08
Q1 FY2025-7.85%
Report Date
Feb 28, 2025
EPS Beat/Miss
+0.0%
Price Before
$3.31
Price After
$3.05
Q4 FY2024+1.85%
Report Date
Nov 1, 2024
EPS Beat/Miss
+0.0%
Price Before
$1.08
Price After
$1.10
Q3 FY2024+17.26%
Report Date
Aug 2, 2024
EPS Beat/Miss
-3.6%
Price Before
$0.68
Price After
$0.80
Avg Beat Reaction+8.11%
Avg Miss Reaction-6.52%
Beat Rate4 / 8 quarters
Largest Move+25.71% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RPID ends December
Rapid Micro Biosystems, Inc. (RPID) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.31 — missing the analyst consensus of $-0.25 by -24.0%. The next RPID earnings date is expected around September 1, 2026.
Each quarter, investors track RPID earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RPID revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RPID's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RPID earnings · 5 questionsRapid Micro Biosystems, Inc.'s next earnings report is expected around September 1, 2026. RPID typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RPID historically reports after market close (AMC).
RPID earnings datewhen is RPID earningsRPID next earnings datewhen does RPID report earningsRPID earnings calendar
▸ Source: FMP · Rapid Micro Biosystems, Inc. SEC filings · US GAAP · Rapid Micro Biosystems, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026